- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT04719533
Outcomes Following Pre-marking of Episiotomy Location
Short and Long Term Outcomes of Patients With and Without Pre-marked Episiotomy Location
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Purpose: To compare short- and long-term outcomes of women following episiotomy during the second stage of labor, following marking of episiotomy location during the first stage of labor with those of women who underwent episiotomy without marking.
Hypothesis: Women following episiotomy following pre-marking of the location will suffer from fewer short- and long-term complications compared to those without pre-marked episiotomy location.
Study type: prospective randomized-controlled trial
Studientyp
Einschreibung (Voraussichtlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
- Name: Sharon Davidesko, MD
- Telefonnummer: +972546837362
- E-Mail: shazadmoni85@gmail.com
Studienorte
-
-
-
Be'er Sheva, Israel, 84101
- Rekrutierung
- Soroka University Medical Center
-
Kontakt:
- Sharon Davidesko, MD
- Telefonnummer: +972546837362
- E-Mail: shazadmoni85@gmail.com
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- women 18 years of age or older who present in active labour to our center and consent to participate in the study
Exclusion Criteria:
- women under 18 years of age or those who do not or are unable to provide informed consent to participate in the study
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Verhütung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
---|---|
Experimental: Pre-marked episiotomy location
Women in this group will undergo pre-marking of episiotomy location
|
A template marking the pre-determined correct location of episiotomy will be used to mark to women in the interventional group
|
Kein Eingriff: No pre-marked episiotomy location
Women in this group will not undergo pre-marking of episiotomy location
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Extended laceration of the episiotomy
Zeitfenster: Up to 1 hour following the episiotomy
|
Additional perineal tears originating from the original episiotomy, as described in the birth chart
|
Up to 1 hour following the episiotomy
|
Third- and fourth-degree perineal tears
Zeitfenster: Up to 2 hours following the episiotomy
|
Perineal tears involving the anal sphincter in addition to the episiotomy, as documented in hospital records
|
Up to 2 hours following the episiotomy
|
Post-partum hemorrhage
Zeitfenster: Up to 6 weeks following delivery
|
Early (<24 hours) or later (24 hours to 6 weeks) hemorrhage following delivery requiring physician intervention as documented in medical records
|
Up to 6 weeks following delivery
|
Blood transfusion requirement
Zeitfenster: Up to 5 days following delivery
|
Any requirement for blood products following delivery as documented in the hospital discharge
|
Up to 5 days following delivery
|
Episiotomy site infection
Zeitfenster: Up to 6 weeks following delivery
|
any documented infection of the episiotomy site treated in ambulatory or hospital setting, as recorded in medical records
|
Up to 6 weeks following delivery
|
Requirement of resuturing of episiotomy or evacuation of hematoma
Zeitfenster: up to 6 weeks following delivery
|
Any additional surgical intervention required relating to the episiotomy, as recorded in medical records
|
up to 6 weeks following delivery
|
Long-term symptoms related to episiotomy
Zeitfenster: Up to 5 years following delivery
|
Any symptoms including perineal pain, dyspareunia, urine incontinence or fecal incontinence as reported by women using a numerical scale or dichotomic scale where appropriate
|
Up to 5 years following delivery
|
Perineal tears in subsequent deliveries
Zeitfenster: Up to 5 years following delivery
|
As recorded in hospital records
|
Up to 5 years following delivery
|
Surgical correction of episiotomy
Zeitfenster: Up to 5 years following delivery
|
Any additional surgical procedures required for correction of episiotomy related symptoms as recorded in medical records
|
Up to 5 years following delivery
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Sharon Davidesko, MD, Soroka University Medical Center
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Voraussichtlich)
Studienabschluss (Voraussichtlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- SOR-0089-20-CTIL
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .